Ming-Qing Huang Selected Research

alisol B 23-acetate

1/2021	Alisol B 23-Acetate Ameliorates Azoxymethane/Dextran Sodium Sulfate-Induced Male Murine Colitis-Associated Colorectal Cancer via Modulating the Composition of Gut Microbiota and Improving Intestinal Barrier.
7/2016	Effects of alisol B 23-acetate on ovarian cancer cells: G1 phase cell cycle arrest, apoptosis, migration and invasion inhibition.
1/2015	Anti-proliferative activities of terpenoids isolated from Alisma orientalis and their structure-activity relationships.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming-Qing Huang Research Topics

Disease

8	Neoplasms (Cancer) 03/2022 - 06/2003
3	Neoplasm Metastasis (Metastasis) 10/2016 - 12/2012
2	Body Weight (Weight, Body) 01/2021 - 01/2021
2	Insulin Resistance 01/2021 - 01/2021
2	Hyperglycemia 01/2021 - 01/2016
1	Lung Neoplasms (Lung Cancer) 03/2022
1	Rheumatoid Arthritis 01/2022
1	Arthritis (Polyarthritis) 01/2022
1	Hyperlipidemias (Hyperlipidemia) 01/2021
1	Colitis-Associated Neoplasms 01/2021
1	Obesity 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 07/2016
1	Glucose Intolerance 01/2016
1	Dyslipidemias (Dyslipidemia) 01/2016
1	Abdominal Aortic Aneurysm 05/2014
1	Breast Neoplasms (Breast Cancer) 01/2013
1	Neointima 07/2010
1	Hematologic Neoplasms (Hematological Malignancy) 06/2003
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2003
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2003
1	Blast Crisis (Blast Phase) 06/2003
1	Myeloid Leukemia (Leukemia, Myelocytic) 06/2003
1	Residual Neoplasm 06/2003

Drug/Important Bio-Agent (IBA)

3	TriterpenesIBA 01/2021 - 01/2015
3	alisol B 23-acetateIBA 01/2021 - 01/2015
2	CytokinesIBA 01/2022 - 01/2021
2	alisol AIBA 01/2021 - 01/2015
2	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2016
2	alisol BIBA 01/2021 - 01/2015
1	ginsenoside Rh2IBA 03/2022
1	Everolimus FDA Link 03/2022
1	MTOR InhibitorsIBA 03/2022
1	CaspasesIBA 03/2022
1	TOR Serine-Threonine KinasesIBA 03/2022
1	geduninIBA 01/2022
1	oxidized low density lipoproteinIBA 01/2021
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2021
1	Acetates (Acetic Acid Esters)FDA Link 01/2021
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	CholesterolIBA 01/2021
1	Dextrans (Dextran)FDA Link 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	fucoxanthinIBA 01/2021
1	HDL LipoproteinsIBA 01/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	AzoxymethaneIBA 01/2021
1	SaponinsIBA 10/2016
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2016
1	Cyclin D1IBA 07/2016
1	GlycogenIBA 01/2016
1	salvianolic acid BIBA 01/2016
1	alisol A 24-acetateIBA 01/2015
1	ChemokinesIBA 05/2014
1	plumbaginIBA 03/2013
1	shikoninIBA 03/2013
1	lapacholIBA 03/2013
1	QuinonesIBA 03/2013
1	jugloneIBA 03/2013
1	thymoquinoneIBA 03/2013
1	aloe emodinIBA 03/2013
1	Antimalarials (Antimalarial Agents)IBA 01/2013
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2013
1	artenimol (dihydroartemisinin)IBA 01/2013
1	Terpenes (Terpenoids)IBA 12/2012
1	Atorvastatin (Lipitor)FDA Link 07/2010
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 07/2010
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 07/2010
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 07/2010
1	Messenger RNA (mRNA)IBA 07/2010
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 06/2003
1	DNA (Deoxyribonucleic Acid)IBA 06/2003

Therapy/Procedure

1	Aftercare (After-Treatment) 01/2021
1	Therapeutics 12/2012